Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
[8-K] SeaStar Medical Holding Corp Reports Ma...
SeaStar Medical Holding Corp. (NASDAQ: ICU) reported strong financial results for 2025, with net revenue significantly increasing to $1.23 million from $135 thousand in 2024, driven by QUELIMMUNE therapy sales. The company also reduced its net loss and improved its cash position. Key business achievements include expanding QUELIMMUNE’s customer base, completing enrollment in a pediatric post-marketing registry, and advancing pivotal trials for adult Acute Kidney Injury (AKI) and cardio-renal conditions.